EW

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Edwards Lifesciences Corp

Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. Edwards Lifesciences is driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.
CEO
Michael Mussallem
Employees
14900
Headquarters

1 Edwards Way
Irvine, California 92614-5688
Phone: 19492502500
www.edwards.com

News

Edwards Lifesciences Corporation (NYSE: EW) Continues To Be Hot This Week?
Nov 23, 2022 13:30pm

Edwards Lifesciences Corporation (NYSE:EW) traded at $74.31 at close of the session on Tuesday, 11/22/22, made an upward move of 0.28% on its previous day’s price. Looking at the stock we see that its previous close was $74.10 and the beta (5Y monthly) reads 1.14 with the day’s price range being $72.92 – $74.60. The … Edwards Lifesciences Corporation (NYSE: EW) Continues To Be Hot This Week? Read More »


Source:Stocks Register
Edwards Lifesciences Corporatio – Consensus Indicates Potential 27.2% Upside
Nov 23, 2022 13:09pm

Edwards Lifesciences Corporatio found using ticker (EW) now have 22 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 128 and 73 with the average target price sitting at 94.27. Now with the previous closing price of 74.1 this would imply there is a potential upside of 27.2%. The 50 day MA is 80.89 and the 200 day MA is 97.79. The market cap for the company is $45,943m. Company Website: https://www.edwards.com [stock_market_widget type="chart" template="basic" color="green" assets="EW" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $58,449m based on the market concensus. Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases.


Source:DirectorsTalk
5 Biggest Medical Device Companies in the World
Nov 20, 2022 20:45pm

In this article we will take a look at the 5 biggest medical device companies in the world. If you want to know more about the industry and discover additional companies, take a look at 15 Biggest Medical Device Companies in the World. 5. Edwards Lifesciences Corporation (NYSE:EW) Market Cap as of November 18: $45.58 […]


Source:Insider Monkey
Our Attention Has Been Attracted to Edwards Lifesciences Corporation (NYSE:EW)
Nov 18, 2022 18:00pm

Edwards Lifesciences Corporation (EW)’s stock is trading at $74.80 at the moment marking a rise of 1.47% from the last session close. As of this writing, shares are priced at -43.22% less than their 52-week high of $131.73, and 11.43% over their 52-week low of $67.13. Based on the past 30-day period, the stock price […]


Source:US Post News
Enovis introduces DynaNail Helix for hindfoot fusions
Nov 18, 2022 00:00am

Enovis Corp. (NYSE: ENOV) has launched the DynaNail Helix —the latest addition to its DynaNail family and suite of foot and ankle products. As with other DynaNail systems, DynaNail Helix uses proprietary, nitinol-based materials technology. The NiTiNOL tech provides sustained dynamic compression properties for subtalar fusion. At the same time, Enovis sought to give it […]


Source:WTWH
Insider Alert: An Insider Just Sold Edwards Lifesciences Corp Shares
Nov 15, 2022 18:30pm

Related Stocks: EW ,


Source:GuruFocus
Chronus Announces Cohort Sistas as Recipient for the Mentoring for Racial Equity Grant Program
Nov 10, 2022 14:00pm

Chronus'' grant program spotlights the impact of educational and professional mentoring for underrepresented groups SEATTLE, WA / ACCESSWIRE / November 10, 2022 / Chronus , the leading enterprise mentoring platform, today announces Cohort Sistas as the grant recipient for Chronus'' 2022 Mentoring for Racial Equity grant program. Cohort Sistas provides digital resources, mentorship and community for Black women and non-binary people pursuing research doctorates. The organization will be given a three-year pro bono contract for Chronus mentoring software and services to support their growing mentoring initiatives. Additionally, Cohort Sistas will receive a $7,500 cash gift to facilitate the setup and assistance in getting the program up and running. Cohort Sistas believe that Black women and nonbinary people should be able to enter, complete and thrive in doctoral programs with the same support and opportunities as other students. These support systems include institutional, financial, socioemotional and mentorship opportunities.


Source:Accesswire
Edwards Lifesciences executes $750M accelerated share repurchase (NYSE:EW)
Nov 01, 2022 13:16pm

Edwards Lifesciences (EW) has announced an accelerated share repurchase agreement to repurchase $750M of its common stock. Under the terms of this agreement, the medical technology…


Source:Seeking Alpha
EDWARDS LIFESCIENCES ANNOUNCES $750 MILLION ACCELERATED SHARE REPURCHASE
Nov 01, 2022 13:00pm

IRVINE, Calif., Nov. 1, 2022 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced that it has executed an accelerated share repurchase agreement ("ASR") to repurchase $750 million of Edwards'' common stock. With this transaction, Edwards has repurchased more than $1.7 billion of…


Source:PR Newswire
Weibo, XPeng, Li Auto And Other Big Losers From Friday
Oct 31, 2022 09:44am

U.S. stocks closed higher on Friday, with the Dow Jones gaining more than 800 points. Here is the list of some big stocks recording losses in the previous session. DaVita Inc. (NYSE: DVA ) shares dipped 27.1% to close at $70.54 after the company reported worse-than-expected Q3 EPS and sales results and lowered FY22 adjusted EPS guidance below estimates. LeMaitre Vascular, Inc. (NASDAQ: LMAT ) declined 19.1% to close at $41.94 after the company reported worse-than-expected Q3 EPS and sales results. The company also issued Q4 EPS and FY22 EPS and sales guidance below analyst estimates. Edwards Lifesciences Corporation (NYSE: EW ) dropped 17.9% to close at $70.87 after the company reported worse-than-expected Q3 results. The company also lowered its FY22 EPS guidance below analyst estimates. United Fire Group, Inc. (NASDAQ: UFCS ) dropped 17.7% to close at $26.12 after Piper Sandler downgraded the stock from Overweight to Neutral and lowered its price target from $37 to $31. Carlisle Companies Incorporated (NYSE: CSL ) declined 15.4% to close at $239.41 after the company reported Q3 earnings results.


Source:Benzinga
Edwards Lifesciences: Opening My Heart (NYSE:EW)
Oct 30, 2022 10:16am

Edwards Lifesciences has seen share price cut nearly in half from its highs. Current multiples remain demanding. Click here to read my analysis of EW stock.


Source:Seeking Alpha
Edwards Lifesciences Plunges Post-Earnings, Bears In Control (NYSE:EW)
Oct 28, 2022 19:50pm

Edwards Lifesciences reported a poor Q3 and slashed guidance and it appears bears are now in control. Click here to read my earnings analysis of EW stock.


Source:Seeking Alpha
Why Edwards Lifesciences Stock Crashed 16% Today
Oct 28, 2022 17:14pm

Did investors overreact to the company''s miss?


Source:The Motley Fool
Economic Challenges Hit Edwards Lifesciences Q3 Earnings, Guidance Lags Wall Street Estimates
Oct 28, 2022 16:25pm

Edwards Lifesciences Corp (NYSE: EW ) reported Q3 adjusted EPS of $0.61 , up 13% Y/Y, missing the Wall Street consensus of $0.62. The company saw persistent U.S. hospital staffing shortages and COVID headwinds in Japan affect its TAVR sales. Edwards'' TAVR sales only grew 1% Y/Y in Q3, reaching $862 million. In the U.S., Edwards'' TAVR procedures increased in … Full story available on Benzinga.com


Source:Benzinga
Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday''s Mid-Day Session
Oct 28, 2022 16:12pm

Gainers Quanergy Systems, Inc. (NASDAQ: QNGY ) surged 179% to $3.6301. Nuvalent, Inc. (NASDAQ: NUVL ) shares jumped 62% to $35.60 after the company reported preliminary Phase 1 clinical data from the ARROS-1 trial that support the best-in-class potential of NVL-520 for patients with ROS1-positive NSCLC. Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ) climbed 38% to $0.7860 after jumping 15% on Thursday. Sierra Metals Inc. (NYSE: SMTS ) gained 32% to $0.2201. Sierra Metals'' largest shareholder and Compañia Minera Kolpa announced Letter of Intent for Sierra Metals transaction and financing. Rail Vision Ltd. (NASDAQ: RVSN ) jumped 31.6% to $0.7899. Agrify Corporation (NASDAQ: AGFY ) surged 31% to $2.1657. Agrify issued an update on its at-the-market equity program. Data I/O Corporation (NASDAQ: DAIO ) gained 25% to $3.8485 after the company reported better-than-expected Q3 results. Provident Acquisition Corp. (NASDAQ: PAQC ) shares gained 22.4% to $10.15. Perfect Corp. and Provident Acquisition Corp. recently announced approval of business combination by Provident''s shareholders.


Source:Benzinga
ACGL Replaces Twitter in S&P 500; EW, COHU Move Big on Q3
Oct 28, 2022 16:01pm

Shares of Arch Capital, Edwards Lifesciences, and Cohu are the standout movers today. Insurance, reinsurance, and mortgage insurance provider Arch Capital (NASDAQ:ACGL) is replacing Twitter in the S&P 500 from November 1. Earlier, the company delivered robust third-quarter numbers with the top line rising 28% year-over-year to $2.47 billion, comfortably surpassing estimates by $20 million. Additionally, EPS at $0.28 outperformed expectations by $0.08. Shares of healthcare products provider Edwards Lifesciences (NYSE:EW), on the other hand, are slumping today after its Q3 numbers missed the cut. Revenue increased marginally by 0.8% over the prior year to $1.32 billion but lagged expectations by $10 million. EPS of $0.


Source:TipRanks
Apple Gets Out of Earnings Alive, Musk Owns Twitter and Friday Afternoon’s Top Analyst Upgrades and Downgrades – 24/7 Wall St.
Oct 28, 2022 15:10pm

Friday’s additional top analyst upgrades and downgrades were on Axalta Coating Systems, Caterpillar, DigitalOcean, Edwards Lifesciences, First Solar, Gilead Sciences, Intel, Stanley Black & Decker, Unity Software, Western Union and more.


Source:24/7 Wall street
Edwards Lifesciences Corp (EW) Q3 2022 Earnings Call Transcript
Oct 28, 2022 01:45am

Edwards Lifesciences Corp (NYSE:NYSE:EW) Q3 2022 Earnings Conference Call October 27, 2022, 17:00 ET Company Participants Mark Wilterding - VP, IR Michael Mussallem - Chairman & CEO…


Source:Seeking Alpha
Edwards Lifesciences down 11% after Q3 misses, revised 2022 EPS guidance (EW)
Oct 27, 2022 22:14pm

Edwards Lifesciences (EW) is down 11% in after-hours trading after the company Q3 2022 top and bottom line results missed and its full-year adjusted EPS guidance range was amended.


Source:Seeking Alpha
Edwards Lifesciences Cuts FY22 Outlook; Shares Tank 10%
Oct 27, 2022 22:04pm

WASHINGTON (dpa-AFX) - Shares of Edwards Lifesciences Corporation (EW) tanked over 10% on Thursday''s extended session after the company lowered its full-year financial outlook.Looking forward, the…


Source:Finanz Nachrichten
Edwards Lifesciences Corp. Q3 Profit Increases, but misses estimates
Oct 27, 2022 21:22pm

WASHINGTON (dpa-AFX) - Edwards Lifesciences Corp. (EW) reported a profit for its third quarter that increased from the same period last year but missed the Street estimates.The company''s bottom li…


Source:Finanz Nachrichten
Edwards Slashes 2022 Profit Outlook, Citing Hospital, Dollar Challenges
Oct 27, 2022 20:30pm

Edwards Lifesciences slashed its 2022 profit outlook on Thursday, noting hospital and dollar challenges. But EW stock remained muted.


Source:Investor''s Business Daily
Edwards Lifesciences''s Earnings: A Preview
Oct 26, 2022 14:13pm

Edwards Lifesciences (NYSE: EW ) is set to give its latest quarterly earnings report on Thursday, 2022-10-27. Here''s what investors need to know before the announcement. Analysts estimate that Edwards Lifesciences will report an earnings per share (EPS) of $0.62. Edwards Lifesciences bulls will hope to hear the company to announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for … Full story available on Benzinga.com


Source:Benzinga
Edwards Lifesciences Corporatio – Consensus Indicates Potential 33.0% Upside
Oct 26, 2022 12:40pm

Edwards Lifesciences Corporatio found using ticker (EW) have now 20 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 130 and 91 with a mean TP of 112.9. Now with the previous closing price of 84.91 this would indicate that there is a potential upside of 33.0%. The day 50 moving average is 89.2 and the 200 day MA is 101.74. The market capitalisation for the company is $53,129m. Find out more information at: https://www.edwards.com [stock_market_widget type="chart" template="basic" color="green" assets="EW" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $70,643m based on the market concensus. Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases.


Source:DirectorsTalk
Miach Orthopedics names Arjun Ishwar as VP of sales and marketing
Oct 11, 2022 00:00am

Miach Orthopedics today announced it appointed Arjun Ishwar as VP of sales and marketing. Iswar brings experience in corporate strategic planning and execution, sales and marketing leadership and commercialization to the Westborough, Massachusetts-based company. He will lead Miach’s commercialization efforts for the Bridge-Enhanced ACL Restoration (BEAR) Implant, which launched in the U.S. in fall 2021. […]


Source:WTWH
SunCommon adds 48.6-kW solar array to Wave Farm arts and broadcast center
Oct 11, 2022 00:00am

Wave Farm, a non-profit arts organization and pioneer of the Transmission Arts genre, has collaborated with SunCommon to solarize its 29-acre campus, including a Study Center and a dozen media art installations, as well as its FM broadcast tower site, by replacing non-renewable energy sources with 48.6 kW of solar power. SunCommon, an iSun company…


Source:WTWH
Small but mighty medical fiber: Minimally invasive surgery demands new materials
Oct 11, 2022 00:00am

High-strength, lightweight medical fiber helps make surgical procedures more effective. Zachary Murnane, Honeywell The first minimally invasive surgery (MIS) — an endoscopy — dates back hundreds of years. In orthopedics, it has a history of a century or more. Uptake has accelerated more recently, and has grown fast across a wide range of surgeries in…


Source:WTWH
Bone Biologics prices $5.1M offering
Oct 07, 2022 00:00am

Bone Biologics (Nasdaq:BBLG) announced today that it priced an underwritten public offering worth $51. million. The offering includes nearly 3.8 million units of securities. Each unit costs $1.35. The gross proceeds total $5.1 million before deducting underwriting discounts and commissions, plus other offering expenses. Each unit features one share of common stock. They also include […]


Source:WTWH
What will the future hold for Edwards Lifesciences Corporation (NYSE:EW) stock?
Oct 06, 2022 17:54pm

Edwards Lifesciences Corporation (EW)’s stock has witnessed a price declined of -0.22% from the previous close with its current price standing at $87.25. Its current price is -33.77% under its 52-week high of $131.73 and 6.57% more than its 52-week low of $81.87. Based on the past 30-day period, the stock price is -11.07% below […]


Source:US Post News
Can you now get a good deal on Edwards Lifesciences Corporation’s shares?
Sep 30, 2022 12:32pm

The share price of Edwards Lifesciences Corporation (NYSE:EW) fell to $83.83 per share on Thursday from $84.24. While Edwards Lifesciences Corporation has underperformed by -0.49%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, EW fell by -26.15%, with highs and lows ranging from $131.73 to $81.87, […]


Source:US Post News
Edwards Lifesciences Corporatio – Consensus Indicates Potential 38.9% Upside
Sep 28, 2022 12:10pm

Edwards Lifesciences Corporatio found using ticker (EW) now have 18 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 130 and 97 with a mean TP of 116.11. Given that the stocks previous close was at 83.59 this would indicate that there is a potential upside of 38.9%. The day 50 moving average is 96.99 while the 200 day moving average is 105.96. The market capitalisation for the company is $51,065m. Company Website: https://www.edwards.com [stock_market_widget type="chart" template="basic" color="green" assets="EW" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $70,931m based on the market concensus. Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases.


Source:DirectorsTalk